cGMP drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (10)
Papers in which this entity is mentioned.
- Prenatal Environment That Affects Neuronal Migration. (2019)
- Genetic absence of nNOS worsens fetal alcohol effects in mice. II: microencephaly and neuronal losses. (2015)
- New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy. (2014)
- Nitric oxide rescues thalidomide mediated teratogenicity. (2012)
- Fetal alcohol spectrum disorders and abnormal neuronal plasticity. (2011)
- Therapeutic utility of phosphodiesterase type I inhibitors in neurological conditions. (2011)
- Molecular assays for characterization of alternatively spliced isoforms of the u opioid receptor (MOR). (2010)
- Phosphatidylinositol 3-kinase/protein kinase Cdelta activation induces close homolog of adhesion molecule L1 (CHL1) expression in cultured astrocytes. (2010)
- Spatial genetic patterning of the embryonic neuroepithelium generates GABAergic interneuron diversity in the adult cortex. (2007)
- Origins of cortical interneuron subtypes. (2004)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| cgmp | drug | 10 | 21 |
| cyclic gmp | drug | — | — |